FRE.DE
Stock Details
FRE.DE is Fresenius SE & Co. KGaA's stock. Stock exchange XETRA (Currency EUR). Average price in 50 days is 33.37€. Average daily volumn in 3 months 1.4M. Market cap 21.58B
Stock symbol : FRE.DE. Exchange : XETRA. Currency : EUR Lastest price : 32.51€. Total volume : 1.08M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Fresenius SE & Co. KGaA (FRE.DE)
Last Price
32.51€Change
0.33Volume
1.08M
| Previous Close | 31.79 |
| Open | 32.01 |
| Day Range | 31.80-32.48 |
| Bid | 32.27 x N/A |
| Ask | 32.29 x N/A |
| Volume | 1.08M |
| Average Volume | 1.4M |
| Market Cap | 21.58B |
| Beta | 1.27 |
| 52 Week Range | 26.69-47.60 |
| Trailing P/E | 10.52 |
| Foward P/E | 9.03 |
| Dividend (Yield %) | 2.76% |
| Ex-Dividend Date | 2022-05-16 |
Financial Details
Organization
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi s... egment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Market Cap:
21.58BRevenue:
37.52BTotal Assets:
71.96BTotal Cash:
2.76B
News about "Fresenius SE & Co. KGaA"
Fresenius SE & Co. KGaA (FRA:FRE) PT Set at €36.00 by Deutsche Bank Rese…
Source from : Defense World - 2 days ago
Fresenius SE & Co. KGaA (FRA:FRE – Get Rating) received a €36.00 ($38.30) price target from Deutsche Bank Rese… in a research note issued on Thursday, Borsen Zeitung reports. Deutsche Bank Rese…’s ...See details»
Fresenius SE & Co. KGaA (FRA:FRE) Given a €33.30 Price Target by JPMorgan Chase & Co. Analysts
Source from : Defense World - 2 days ago
JPMorgan Chase & Co. set a €33.30 ($35.43) target price on Fresenius SE & Co. KGaA (FRA:FRE – Get Rating) in a research report released on Wednesday morning, Borsen Zeitung reports. Other equities ...See details»
Fresenius SE & Co. KGaA (FRE) – Analysts’ Weekly Ratings Updates
Source from : ETF Daily News - 3 days ago
Fresenius SE & Co. KGaA has a fifty-two week low of €60.16 ($64.00) and a fifty-two week high of €80.00 ($85.11). Fresenius SE & Co KGaA, a health care company, provides products and services ...See details»
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Downgraded by Zacks Investment Research to Sell
Source from : ETF Daily News - 9 days ago
Zacks Investment Research lowered shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Rating) from a hold rating to a sell rating in a research report report published on Wednesday ...See details»
Fresenius SE & Co KGaA - Stock Quote FSNUF
Source from : Morningstar%2c Inc. - 4 days ago
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...See details»
Fresenius SE & Co. KGaA ADR
Source from : Wall Street Journal - 3 days ago
1 Day FSNUY 0.61% DJIA 0.60% S&P 500 0.95% Health Care/Life Sciences -0.37% ...See details»
Fresenius SE & Co KGaA - Stock Dividends FRE
Source from : Morningstar%2c Inc. - 5 days ago
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»
DGAP-DD: Fresenius SE & Co. KGaA english
Source from : Business Insider - 8 days ago
Archive at www.dgap.de 75275 20.05.2022 SHARE THIS POST Fresenius NewsMORE Related Stocks Find News News ...See details»
Fresenius Medical Care AG & Co. KGaA
Source from : Wall Street Journal - 12 days ago
Fresenius Medical Care AG & Co. KGaA, Fresenius Management SE, Else Kröner-Fresenius-Stiftung Dorothea Wenzel Member-Supervisory Board Fresenius Medical Care AG & Co. KGaA, H. Lundbeck A/S ...See details»
Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care
Source from : dgap - 24 days ago
Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel Fresenius Medical Care ... Dr. Carla Kriwet will also be a member of the Management Board of Fresenius Management SE. Fresenius Medical ...See details»
Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care
Source from : dgap - 24 days ago
DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel Fresenius Medical Care ... Dr. Carla Kriwet will also be a member of the Management Board of Fresenius Management SE. Helen ...See details»
Local Anesthesia Drugs Market Size, Trends, Growth Analysis and Forecast from 2022-2028 | Pfizer Inc, Fresenius Se & Co. Kgaa, Aspen Pharmacare
Source from : Digital Journal - 12 days ago
Gravitas Market Insights provides in-depth research of the Local Anesthesia Drugs Market with complete insights into significant factors and characteristics impacting the potential growth of the ...See details»
Fresenius SE & Co KGaA
Source from : Newsweek - 1 month ago
Fresenius SE & Co. KGaA is a European health care company based in Bad Homburg, Germany. The Fresenius Group provides products and services for dialysis, hospitals as well as inpatient and ...See details»
DGAP-DD: Fresenius SE & Co. KGaA english
Source from : Business Insider - 9 days ago
Archive at www.dgap.de 75201 19.05.2022 SHARE THIS POST Fresenius NewsMORE Related Stocks Find News News ...See details»